The lawsuit unfolding in Baltimore County isn’t just about melatonin—it’s about the quiet, unregulated experiments happening in classrooms across America, where parents are only learning about the risks after the fact. At the center of the storm is Baltimore County Public Schools, accused by a group of parents of administering melatonin to students with cognitive disabilities without proper consent or medical oversight. But this isn’t an isolated incident. It’s the latest chapter in a growing crisis where schools, desperate to manage behavioral challenges in the absence of federal guidance, are turning to off-label treatments—often with little transparency and even less accountability.
What’s missing from the initial reports? The systemic failures that allowed this to happen, the legal gray areas around school-administered medications, and the broader implications for parents, educators, and policymakers. Archyde has dug deeper to uncover the full story—because this isn’t just a local dispute. It’s a warning sign for how America’s schools are navigating the uncharted territory of pharmacological interventions in an era where mental health crises among children are at record highs.
The School District’s Melatonin Gambit: A Pattern of Unchecked Experimentation
The lawsuit, filed by the law firm Kline & Specter on behalf of a group of parents, alleges that Baltimore County Public Schools (BCPS) administered melatonin to students at Woodlawn High School’s Special Education Center without parental knowledge or explicit medical authorization. The parents claim their children—some as young as 12—were given doses of the sleep aid as part of a behavioral management program, despite melatonin’s lack of FDA approval for children under 18 in this context.
Here’s the kicker: BCPS isn’t the first district to walk this tightrope. In Florida, a 2023 investigation by the Miami Herald revealed that at least 17 school districts had administered melatonin to students, often to address sleep disorders or behavioral issues. Meanwhile, in California, a 2024 lawsuit against the Los Angeles Unified School District accused officials of giving Adderall to students without proper oversight. The pattern is clear: when schools feel ill-equipped to handle behavioral health crises, they’re improvising with medications that were never designed for classroom use.
But why melatonin? The drug, originally approved for sleep disorders in adults, has been marketed as a “natural” sleep aid for children, creating a perception of safety that masks its risks. Side effects—ranging from hormonal disruptions to seizures in rare cases—are rarely discussed in school board meetings. Yet, according to Dr. Rachel Goldman, a pediatric psychologist at NYU Langone Health, the long-term effects of chronic melatonin use in children remain largely unstudied.
“We’re dealing with a generation of kids whose brains are still developing, and we’re giving them substances with unknown neurobiological impacts. The fact that schools are doing this without parental consent is especially troubling—it’s not just a medical issue, it’s an ethical one.”
—Dr. Rachel Goldman, Pediatric Psychologist, NYU Langone Health
Legal Loopholes: Why Schools Can Get Away With This
The lawsuit hinges on a critical question: Who is responsible when a school administers medication without a prescription? The answer, as it turns out, is no one. Federal law, under the Individuals with Disabilities Education Act (IDEA), allows schools to provide related services—including medication management—to students with disabilities. But the law is vague about the specifics of who can administer drugs, how, and with whose permission.
Enter the School Health Aides—often underpaid, minimally trained staff who are increasingly tasked with dispensing medications in schools. A 2025 report by the American Academy of Pediatrics found that 42% of U.S. School districts lack formal policies on medication administration, leaving room for ad hoc decisions. In Baltimore County, parents say their children were given melatonin by aides who weren’t licensed nurses, raising questions about competency and accountability.
The legal gray area extends to consent. While some states require parental permission for medication administration, others—like Maryland—only mandate it for prescription drugs. Melatonin, sold over-the-counter, often slips through the cracks. “The system is designed to fail parents,” says Attorney Mark Specter, who is leading the Baltimore County case. “Schools have broad discretion, and parents are left in the dark until something goes wrong.”
“This isn’t just about melatonin. It’s about the broader erosion of parental rights in education. Schools are making medical decisions that should be left to doctors and families.”
—Mark Specter, Partner, Kline & Specter LLP
The Melatonin Economy: How Considerable Pharma and Schools Profit from the Crisis
Behind the classroom door, there’s a $1.2 billion industry pushing sleep aids for children. Melatonin sales in the U.S. Have surged 450% since 2018, driven in part by marketing campaigns framing it as a “harmless” solution for insomnia, ADHD, and autism-related sleep disorders. Yet, the FDA has never approved melatonin for children under 18, and clinical trials on its long-term effects are woefully inadequate.
Schools, meanwhile, are caught in a funding squeeze. With mental health staffing shortages leaving districts understaffed, administrators are turning to pharmacological fixes as a low-cost alternative to therapy. A 2024 study in the Journal of School Health found that 38% of special education teachers reported using off-label medications to manage student behavior, often without input from parents or doctors.
The result? A perverse incentive structure where schools, parents, and pharmaceutical companies all benefit—until a child’s health suffers. “We’re in a moment where schools are being forced to make impossible choices,” says Dr. David F. Walker, a former U.S. Department of Education official who now advises districts on special education policy. “But medication isn’t a substitute for proper funding, training, and support.”
“The real tragedy here is that we’re medicating our way out of systemic failures. Schools need more counselors, more psychologists, and more resources—not more pills.”
—Dr. David F. Walker, Former U.S. Department of Education Official
What Parents Can Do: The Unspoken Playbook for Fighting Back
If you’re a parent whose child attends a school where medications are administered without consent, here’s what you need to know:
- Demand a written policy. Ask your school district for its exact protocol on medication administration. If they don’t have one, request an emergency meeting with the school board.
- Know your state’s laws. Some states, like Texas and Florida, require explicit parental consent for all medications, while others have loopholes. Check your state’s education department website.
- Document everything. Keep records of all communications with school staff. If your child is given medication without your knowledge, file a complaint with the U.S. Department of Education’s Office for Civil Rights.
- Consider legal action. If your child has been harmed, consult an attorney specializing in educational malpractice. The Baltimore County lawsuit sets a precedent—other parents may follow.
The bigger question is: How do we prevent this from happening again? The answer lies in transparency, accountability, and funding. Schools can’t be expected to handle medical decisions without proper training, oversight, and resources. And parents deserve to be informed—not blindsided—when their children are given powerful substances.
So here’s your takeaway: This lawsuit isn’t just about melatonin. It’s about who gets to decide what happens to our kids when we’re not looking. The system is broken, but the fix starts with you. Will you stay silent, or will you demand better?
